Access to anti-retroviral drugs, female in Slovenia

Slovenia: Access to anti-retroviral drugs, female was 83.0% in 2024. ▲ Rising

Latest (2024)
83.0%
Change on year
up 15.3%
World rank
53rd
of 141 countries
All-time high
83.0%
in 2024
All-time low
21.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Slovenia, 2000–2024

204060802000201220242000: 21 %2001: 24 %2002: 23 %2003: 25 %2004: 27 %2005: 27 %2006: 34 %2007: 33 %2008: 35 %2009: 34 %2010: 45 %2011: 44 %2012: 44 %2013: 48 %2014: 52 %2015: 55 %2016: 67 %2017: 75 %2018: 71 %2019: 70 %2020: 73 %2021: 71 %2022: 70 %2023: 72 %2024: 83 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, female in Slovenia stood at 83.0%. That is the highest value across all 25 years on record.

That represents a change of up 15.3% on the previous year and up 59.6% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Slovenia peaked at 83.0% in 2024 and was at its lowest, 21.0%, in 2000.

That places Slovenia 53rd out of 141 countries with data for 2024, putting it in the middle of the range.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, female in Slovenia, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Slovenia, 2000 to 2024.
Year % Change
2000 21.0%
2001 24.0% +14.3%
2002 23.0% -4.2%
2003 25.0% +8.7%
2004 27.0% +8.0%
2005 27.0% +0.0%
2006 34.0% +25.9%
2007 33.0% -2.9%
2008 35.0% +6.1%
2009 34.0% -2.9%
2010 45.0% +32.4%
2011 44.0% -2.2%
2012 44.0% +0.0%
2013 48.0% +9.1%
2014 52.0% +8.3%
2015 55.0% +5.8%
2016 67.0% +21.8%
2017 75.0% +11.9%
2018 71.0% -5.3%
2019 70.0% -1.4%
2020 73.0% +4.3%
2021 71.0% -2.7%
2022 70.0% -1.4%
2023 72.0% +2.9%
2024 83.0% +15.3%

Averages by decade

DecadeAverage LowestHighest Years
2000s 28.3% 21.0% 35.0% 10
2010s 57.1% 44.0% 75.0% 10
2020s 73.8% 70.0% 83.0% 5

Countries ranked near Slovenia

  1. 50 Côte d'Ivoire 84.0% compare
  2. 50 Singapore 84.0% compare
  3. 50 South Africa 84.0% compare
  4. 53 Guinea 83.0% compare
  5. 53 Nepal 83.0% compare
  6. 56 Portugal 82.0% compare

See the full ranking of 160 places →

More gender data for Slovenia

All data for Slovenia →

Frequently asked questions

What is access to anti-retroviral drugs, female in Slovenia?
Access to anti-retroviral drugs, female in Slovenia was 83.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Slovenia?
The highest recorded value was 83.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Slovenia?
The lowest recorded value was 21.0% in 2000.
How does Slovenia rank for access to anti-retroviral drugs, female?
Slovenia ranks 53rd out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Slovenia?
Over the last ten years it is up 59.6%. The long-run trend across the full record is rising.
Where does this Slovenia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Slovenia. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/slovenia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/slovenia/">Access to anti-retroviral drugs, female in Slovenia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.